Current contract manufacturing partners

Pharma sourcing and out-sourcing

The need to reduce costs and extend their presence in emerging markets is leading pharma companies to increasingly examine out-sourcing options.

Demand for contract manufacturing services is growing rapidly with the global contract manufacturing market expected to grow at a CAGR of around 12% during 2010-2012 from a revenue of around US$ 22.5 Billion at the end of 2009. Emerging markets such as India, China, Singapore and Brazil continue to support low cost contract manufacturing, with a further growth in new markets such as Vietnam, South Korea and Bangladesh.*

With a particular focus for sourcing and out-sourcing professionals WDM discusses strategies for reducing costs and dealing with the globalisation of pharma manufacturing. A stream dedicated to these issues runs throughout the event and examines how sourcing and out-sourcing can play a critical role in ensuring the sustained success of the pharmaceutical industry. Key topics include:

• Local vs. low cost - defining the decision making process for identifying the most cost-effective contract manufacturing partners
• Relationship management - Extending operational excellence in to contract manufacturing partners and suppliers
• Global quality- ensuring quality in external manufacturing operations in distant locations
• Overcoming cultural and regulatory barriers to global sourcing and out-sourcing
• COGS reduction through effective procurement
• Technology transfer into contract manufacturing operations

The pharma industry is continuously sourcing new external manufacturing partners. If you are interested in promoting your company at WDM then please contact Maria Villablanca.

Source*:’Global Contract Manufacturing Market Analysis’, RNCOS, June 2010